| ¿µ¹® | ovarian cysts | ÇÑ±Û | ³¼Ò³¶ |
|---|---|---|---|
| ¼³¸í | ³¼Ò¿¡ ¹ß»ýÇÑ ³¶. ¿©±â¿¡´Â ´Ü¼øÇÑ ¹°È¤ÀÎ ³¶ÀÌ ÀÖ°í Á¾¾ç¼º ³¶ÀÌ ÀÖ´Ù. ³¶À̶õ, ¸·À¸·Î µÑ·¯ ½Î¿©Á® ÀÖÀ¸¸ç, ¾È¿¡´Â ¾×ü°¡ Â÷ÀÖ´Â º´Å͸¦ ¸»ÇÑ´Ù. ÀÌ·± ³¶ÇüÅÂÀÇ Á¾¾çÀ¸·Î´Â ÇǺθð¾ç³¶Á¾(dermoid cyst), ³¶»ùÁ¾(cystadenoma) µîÀÌ ÀÖ´Ù. À̵éÀÇ °¨º°Áø´ÜÀº ȯÀÚÀÇ ¿¹ÈÄ¿¡ °áÁ¤ÀûÀ̹ǷΠ¹Ýµå½Ã ½ÃÇàµÇ¾î¾ß Çϳª, ±× ¹æ¹ýÀº ¼ö¼ú¿¡ ÀÇÇØ¼ ³¶Á¾À» ÀýÁ¦ÇÏ¿© º´¸®ÇÐÀûÀ¸·Î ±¸ºÐÇÏ´Â ¼ö¹Û¿¡ ¾ø´Ù. |
||
| ¿µ¹® | ovarian cancer | ÇÑ±Û | ³¼Ò¾Ï |
|---|---|---|---|
| ¼³¸í | ¿©¼ºÀÇ ³¼Ò¿¡ ¹ß»ýÇÏ´Â ¾Ï. ºÎÀΰúÁ¾¾çÀ¸·Î¼ 50¼¼ ÀÌ»ó ¿©¼º¾Ç¼ºÁ¾¾çÀÇ ¾à 18%¸¦ Â÷ÁöÇÑ´Ù. Á¾¾çÀº ´ë°³ º¹ºÎ ±í¼÷È÷ À§Ä¡ÇϹǷΠÁ¾¾çÀÌ ¸¹ÀÌ ÁøÇàµÈ »óÅ¿¡¼ ¹ß°ßµÇ´Â ¼ö°¡ ¸¹À¸¸ç, ¶ÇÇÑ Á¾¾çÀÇ Ãʱ⿡´Â Áõ»óÀÌ °ÅÀÇ ¾ø´Â °æ¿ì°¡ ¸¹¾Æ ´õ¿í Á¶±â¹ß°ßÀÌ ¾î·Æ´Ù. ¾ÆÁÖ ´Ù¾çÇÑ Á¾·ùÀÇ ¾ÏÀÌ ¹ß»ýÇϸç, ¿¹Èĵµ °¢±â ±× Á¾¾çÀÇ Á¾·ù¿¡ µû¶ó ´Ù¸£´Ù. ´ëÇ¥ÀûÀÎ ¾ÏÀ¸·Î À强³¶»ù¾ÏÁ¾(serous cystadenocarcinoma), Á¡¾×³¶»ù¾ÏÁ¾(mucinous cystadenocarcinoma), Á¾ÀÚ¼¼Æ÷Á¾(germinoma µîÀÌ ÀÖ´Ù. Ä¡·á´Â ¼ö¼úÀû Ä¡·á°¡ ¼±ÇàµÇ¾î¾ß ÇÏÁö¸¸, ¸¹ÀÌ ÁøÇàµÇ¾î ÀÌ¹Ì ´Ù¸¥ Á¶Á÷À¸·Î ÀüÀ̰¡ ÀÌ·ç¾îÁø »óÅ¿¡¼´Â ÈÇпä¹ýÀÌ ¼±ÅÃÀûÀ¸·Î »ç¿ëµÈ´Ù. |
||
| ¿µ¹® | white blood cell(WBC), leukocyte | ÇÑ±Û | ¹éÇ÷±¸ |
|---|---|---|---|
| ¼³¸í | Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, ȤÀº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀÎ Çö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | mast cell | ÇÑ±Û | ºñ¸¸ ¼¼Æ÷ |
|---|---|---|---|
| ¼³¸í | µ¿¹°ÀÇ °áÇÕ Á¶Á÷ °¡¿îµ¥ ³Î¸® ºÐÆ÷ÇÏ´Â ¼¼Æ÷. °áÇÕÁ¶Á÷°ú Á¡¸·Á¶Á÷ ³»¿¡ Àִ ȣ¿°±â¼º »ö¼Ò·Î ÀÌ¿°»ö¼º(metachromasia)À» ³ªÅ¸³»´Â °ú¸³À» °¡Áø ¹æÃßÇüÀÇ ¼¼Æ÷¿¡ ÀÛÀº µÕ±Ù ÇÙÀ» °¡Áø´Ù. ºñ¸¸¼¼Æ÷ÀÇ Ç¥¸é¿¡´Â IgE¿¡ ´ëÇÑ ¼ö¿ëü°¡ Á¸ÀçÇϸç, ¼ö¿ëü¿¡ °áÇÕÇÑ IgE ºÐÀڵ鳢¸® ´Ù°¡ÀÇ Ç׿ø¿¡ ÀÇÇØ ¼·Î ¿¬°áµÇ¸é ºñ¸¸¼¼Æ÷ °ú¸³Å»Ãâ ¹ÝÀÀÀÌ ÀϾ, È÷½ºÅ¸¹Î, ¼¼·ÎÅä´Ñ, ÇìÆÄ¸° µîÀÇ ÈÇÐÀü´Þ ¹°ÁúÀÌ ¹æÃâµÇ¾î, Áï½ÃÇü ¾Ë·¹¸£±â ¹ÝÀÀ µîÀÇ Áõ»óÀ» ÀÏÀ¸Å²´Ù. ÇǺÎ, À帷, Ç÷°ü ÁÖÀ§, Á¡¸· ÁÖº¯¿¡ ÀÖ´Ù. |
||
| OCAA | Ovarian Cystadenocarcinoma Associated Antigen; Serous Mucinous Ovarian Tumor¿¡¸¸ ³ªÅ¸³² |
|---|---|
| POF | pattern of failure; position of function; premature ovarian failure; primary ovarian failure; pyruva... |
| MC | mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med... |
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
| GC | ganglion cell; gas chromatography; general circulation; general closure; general condition; generali... |
| GCT | Granular Cell Tumour |
|---|---|
| TNF alpha | Anti-tumour necrosis factor alpha |
| BTB | Blood-Tumour-Barrier |
| BMRTC | Bone metastasising renal tumour of childhood |
| EATC | Ehrlich Ascites tumour cells |
| ovarian granulosa-theca cell tumour | <radiology> Any age, most benign, oestrogens may lead to isosexual precocious puberty (pathognomonic), large tumour with areas of cystic degeneration (12 Dec 1998) |
|---|
| ovarian tumour | <gynaecology, oncology> A malignant tumour of the ovary is the leading cause of death from gynaecologic malignancies. Often diagnosed in later stages, symptoms include abdominal pain, increasing abdominal girth and abnormal uterine bleeding. Birth control pill use is thought to reduce the risk of ovarian cancer. (05 Jan 1998) |
|---|---|
| ovarian granulosa cell | <biology, gynaecology> During oogenesis in mammals the ovarian (Graafian) follicle, in which the developing ovum lies, is lined with follicle cells, the peripheral follicle cells form the stratum granulosum or ovarian granulosa. (05 Jan 1998) |
| acinar cell tumour | A solid and cystic tumour of the pancreas, occurring in young women; tumour cells contain zymogen granules. (05 Mar 2000) |
| malignant giant cell tumour | A type of bone tumour. (12 Dec 1998) |
| germ cell tumour | A type of brain tumour. (12 Dec 1998) |
| giant cell tumour | <radiology> Osteoclastoma, GCT, any age, typically 20-35, site: metaphysis into epiphysis, 50% at knee (distal femur, proximal tibia), long bones, patella, spine, eccentric, expansile, with or without soap bubble appearance, treatment: curette, fill with methacrylate, 10% recur, a few are premalignant or malignant, cannot determine malignancy by XR (12 Dec 1998) |
| giant cell tumour of bone | A bone tumour composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumours range from benign to frankly malignant lesions. The tumour occurs most frequently in an end of a long tubular bone in young adults. (12 Dec 1998) |
| giant cell tumour of tendon sheath | A nodule, possibly inflammatory in nature, arising commonly from the flexor sheath of the fingers and thumb; composed of fibrous tissue, lipid-and haemosiderin-containing macrophages, and multinucleated giant cells. Synonym: localised nodular tenosynovitis. (05 Mar 2000) |
| Merkel cell tumour | A rare malignant cutaneous tumour seen in sun-exposed skin of elderly patients composed of dermal nodules of small round cells with scanty cytoplasm in a trabecular pattern; the tumour cells contain cytoplasmic dense core granules resembling neurosecretory granules seen in Merkel cells. Synonym: primary neuroendocrine carcinoma of the skin, trabecular carcinoma. (05 Mar 2000) |
| granular cell tumour | Unusual tumour affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; however, it is considered to be a myoblastoma of, usually, a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma. (12 Dec 1998) |
| granulosa cell tumour | An ovarian tumour originating in the cells of the primordial membrana granulosa of the graafian follicle. It may be associated with excessive production of estrin, inducing endometrial hyperplasia with menorrhagia. It can be benign or malignant. It is soft, solid, white or yellow, and consists of small round cells sometimes enclosing call-exner bodies. Larger lipid-containing cells may be present. Granulosa cell tumours are seen in women of all ages. Treatment depends on the age of the patient and the extent of the disease. (12 Dec 1998) |
| hilar cell tumour of ovary | A small benign masculinizing ovarian tumour derived from hilar cells, which resemble Leydig cells of the testis. (05 Mar 2000) |
| Hurthle cell tumour | A neoplasm of the thyroid gland composed of polyhedral acidophilic cells, thought by some to be oncocytes; it may be benign or malignant, the behaviour of the latter depending on the general microscopic pattern, whether follicular, papillary, or undifferentiated. See: Hurthle cell adenoma. Synonym: Hurthle cell carcinoma. (05 Mar 2000) |
| sertoli cell tumour | A rare benign tumour of the testis that histologically resembles the foetal testis. There are three varieties: diffuse stromal, mixed (stromal and epithelial), and tubular (epithelial). Sertoli cells in the epithelial elements may produce oestrogen and cause feminization. (12 Dec 1998) |
| sertoli-leydig cell tumour | An ovarian tumour usually of low-grade malignancy occurring most frequently in the third and fourth decades, with 75% seen in women under 40. It is rare, representing less than .02% of ovarian cancers. The tumour typically produces androgens with virilization being noted in 70-85% of the patients. (holland et al., cancer medicine, 3d ed, p1684) (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|